These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23649509)

  • 1. Efficacy of OK-432 sclerotherapy in treatment of lymphatic malformations: long-term follow-up results.
    Weitz-Tuoretmaa A; Rautio R; Valkila J; Keski-Säntti H; Keski-Nisula L; Laranne J
    Eur Arch Otorhinolaryngol; 2014 Feb; 271(2):385-90. PubMed ID: 23649509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lymphatic malformations of head and neck with OK-432 sclerotherapy induce systemic inflammatory response.
    Närkiö-Mäkelä M; Mäkelä T; Saarinen P; Salminen P; Julkunen I; Pitkäranta A
    Eur Arch Otorhinolaryngol; 2011 Jan; 268(1):123-9. PubMed ID: 20635092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OK-432 sclerotherapy of lymphatic malformation in the head and neck: factors related to outcome.
    Kim DW
    Pediatr Radiol; 2014 Jul; 44(7):857-62. PubMed ID: 24569928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of lymphatic malformations with OK-432 (Picibanil): review of the literature.
    Poldervaart MT; Breugem CC; Speleman L; Pasmans S
    J Craniofac Surg; 2009 Jul; 20(4):1159-62. PubMed ID: 19553857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with lymphatic malformations who receive the immunostimulant OK-432 experience excellent long-term outcomes.
    Ghaffarpour N; Petrini B; Svensson LA; Boman K; Wester T; Claesson G
    Acta Paediatr; 2015 Nov; 104(11):1169-73. PubMed ID: 26081020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.
    Chen WL; Huang ZQ; Chai Q; Zhang DM; Wang YY; Wang HJ; Wang L; Fan S
    Int J Oral Maxillofac Surg; 2011 Jun; 40(6):572-6. PubMed ID: 21367582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative adjuvant OK-432 sclerotherapy for treatment of cervicofacial lymphatic malformations: an outcomes comparison.
    Kim SY; Lee S; Seo JM; Lim SY
    Int J Pediatr Otorhinolaryngol; 2015 Apr; 79(4):570-5. PubMed ID: 25698461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.
    Yamaki T; Sasaki Y; Hasegawa Y; Osada A; Konoeda H; Hamahata A; Nozaki M; Sakurai H
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):707-714. PubMed ID: 28818226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphatic malformations in the head and neck: experiences with sclerotherapy].
    Knipping S; Bau V
    HNO; 2011 Jul; 59(7):683-8. PubMed ID: 21509618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality treatment of pediatric lymphatic malformations of the head and neck using surgery and sclerotherapy.
    Boardman SJ; Cochrane LA; Roebuck D; Elliott MJ; Hartley BE
    Arch Otolaryngol Head Neck Surg; 2010 Mar; 136(3):270-6. PubMed ID: 20231646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cystic lymphatic vascular malformations with OK-432 sclerotherapy.
    Peters DA; Courtemanche DJ; Heran MKS; Ludemann JP; Prendiville JS
    Plast Reconstr Surg; 2006 Nov; 118(6):1441-1446. PubMed ID: 17051116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerotherapy for lymphatic malformations of the head and neck in the pediatric population.
    Tu JH; Do HM; Patel V; Yeom KW; Teng JMC
    J Neurointerv Surg; 2017 Oct; 9(10):1023-1026. PubMed ID: 27707871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations.
    Smith MC; Zimmerman MB; Burke DK; Bauman NM; Sato Y; Smith RJ;
    Laryngoscope; 2009 Jan; 119(1):107-15. PubMed ID: 19117316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of doxycycline and sodium tetradecyl sulfate sclerotherapy in pediatric head and neck lymphatic malformations.
    Farnoosh S; Don D; Koempel J; Panossian A; Anselmo D; Stanley P
    Int J Pediatr Otorhinolaryngol; 2015 Jun; 79(6):883-887. PubMed ID: 25887132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OK432 versus doxycycline for treatment of macrocystic lymphatic malformations.
    Motz KM; Nickley KB; Bedwell JR; Yadav B; Guzzetta PC; Oh AK; Bauman NM
    Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):81-8. PubMed ID: 24574462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts in lymphatic malformation.
    Lee BB; Kim YW; Seo JM; Hwang JH; Do YS; Kim DI; Byun HS; Lee SK; Huh SH; Hyun WS
    Vasc Endovascular Surg; 2005; 39(1):67-81. PubMed ID: 15696250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children.
    Nehra D; Jacobson L; Barnes P; Mallory B; Albanese CT; Sylvester KG
    J Pediatr Surg; 2008 Mar; 43(3):451-60. PubMed ID: 18358281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom Resolution and Volumetric Reduction of Abdominal Lymphatic Malformations With Sclerotherapy.
    Madsen HJ; Annam A; Harned R; Nakano TA; Larroque LO; Kulungowski AM
    J Surg Res; 2019 Jan; 233():256-261. PubMed ID: 30502256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of lymphangiomas with OK-432 (Picibanil).
    Rautio R; Keski-Nisula L; Laranne J; Laasonen E
    Cardiovasc Intervent Radiol; 2003; 26(1):31-6. PubMed ID: 12491020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic Toll-like receptor expression predicts outcome of sclerotherapy for lymphatic malformations with OK-432 in children.
    Reismann M; Ghaffarpour N; Luvall E; Jirmo AC; Winqvist O; Radtke J; Wester T; Claesson G
    J Surg Res; 2014 Mar; 187(1):197-201. PubMed ID: 24215906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.